Eagle Pharmaceuticals Analyst Ratings
Eagle Pharmaceuticals (EGRX) Receives a Hold From Piper Sandler
Cantor Fitzgerald Adjusts Eagle Pharmaceuticals Price Target to $33 From $37, Maintains Neutral Rating
Cantor Fitzgerald Adjusts Eagle Pharmaceuticals Price Target to $37 From $45, Maintains Neutral Rating